{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T04:16:54Z","timestamp":1741839414574,"version":"3.38.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinicalimaging.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Imaging"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.clinimag.2025.110416","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T17:01:27Z","timestamp":1738083687000},"page":"110416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A model for prediction of recurrence of non-small cell lung cancer based on clinical data and CT imaging characteristics"],"prefix":"10.1016","volume":"120","author":[{"given":"Xinjie","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dengfa","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengjuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hengfeng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zongyu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenyu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clinimag.2025.110416_bb0005","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"10.1016\/j.clinimag.2025.110416_bb0010","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3322\/caac.21731","article-title":"Cancer treatment and survivorship statistics, 2022","volume":"72","author":"Miller","year":"2022","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.clinimag.2025.110416_bb0015","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","article-title":"The IASLC lung Cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung Cancer","volume":"11","author":"Goldstraw","year":"2016","journal-title":"J Thorac Oncol"},{"issue":"4","key":"10.1016\/j.clinimag.2025.110416_bb0020","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.athoracsur.2012.01.004","article-title":"Results of long-term follow-up of patients with completely resected non-small cell lung cancer","volume":"93","author":"Endo","year":"2012","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.clinimag.2025.110416_bb0025","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.lungcan.2014.01.017","article-title":"A retrospective comparison of adjuvant chemotherapeutic regimens for non-small cell lung cancer (NSCLC): paclitaxel plus carboplatin versus vinorelbine plus cisplatin","volume":"84","author":"Chang","year":"2014","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.clinimag.2025.110416_bb0030","first-page":"169","article-title":"Impact of adjuvant chemotherapy in completely resected stage IIIA non-small cell lung cancer","volume":"68","author":"Naim Younes","year":"2013","journal-title":"Minerva Chir"},{"key":"10.1016\/j.clinimag.2025.110416_bb0035","first-page":"0429","article-title":"Nano-assisted radiotherapy strategies: new opportunities for treatment of non-small cell lung cancer","volume":"7","author":"Zhao","year":"2024","journal-title":"Research (Wash D C)"},{"issue":"8","key":"10.1016\/j.clinimag.2025.110416_bb0040","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1200\/JCO.2012.44.5064","article-title":"New radiotherapy and chemoradiotherapy approaches for non-small-cell lung cancer","volume":"31","author":"Salama","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinimag.2025.110416_bb0045","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.gene.2016.11.007","article-title":"Functional polymorphisms in PD-L1 gene are associated with the prognosis of patients with early stage non-small cell lung cancer","volume":"599","author":"Lee","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.clinimag.2025.110416_bb0050","doi-asserted-by":"crossref","first-page":"35603","DOI":"10.1038\/srep35603","article-title":"Genetic polymorphisms in glycolytic pathway are associated with the prognosis of patients with early stage non-small cell lung cancer","volume":"6","author":"Lee","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.clinimag.2025.110416_bb0055","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.lungcan.2016.09.005","article-title":"Prediction of distant recurrence in resected stage I and II lung adenocarcinoma","volume":"101","author":"Aramini","year":"2016","journal-title":"Lung Cancer"},{"issue":"5","key":"10.1016\/j.clinimag.2025.110416_bb0060","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/j.cllc.2015.12.013","article-title":"Risk factors for local and distant recurrence after surgical treatment in patients with non-small-cell lung Cancer","volume":"17","author":"Dziedzic","year":"2016","journal-title":"Clin Lung Cancer"},{"issue":"2","key":"10.1016\/j.clinimag.2025.110416_bb0065","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s12013-015-0649-x","article-title":"A study of complete video-assisted Thoracoscopic surgery lobectomy in treatment of elderly patients with non-small cell lung Cancer: curative effect and impact on clinical prognosis","volume":"73","author":"Xue","year":"2015","journal-title":"Cell Biochem Biophys"},{"issue":"1","key":"10.1016\/j.clinimag.2025.110416_bb0070","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1038\/s41467-024-47512-0","article-title":"Enhancing NSCLC recurrence prediction with PET\/CT habitat imaging, ctDNA, and integrative radiogenomics-blood insights","volume":"15","author":"Sujit","year":"2024","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.clinimag.2025.110416_bb0075","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1038\/s41467-020-19116-x","article-title":"Non-invasive decision support for NSCLC treatment using PET\/CT radiomics","volume":"11","author":"Mu","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.clinimag.2025.110416_bb0080","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13014-024-02402-z","article-title":"A PET\/CT radiomics model for predicting distant metastasis in early-stage non-small cell lung cancer patients treated with stereotactic body radiotherapy: a multicentric study","volume":"19","author":"Yu","year":"2024","journal-title":"Radiat Oncol"},{"issue":"11","key":"10.1016\/j.clinimag.2025.110416_bb0085","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1007\/s00259-024-06740-8","article-title":"The impact of PET\/CT and brain MRI for metastasis detection among patients with clinical T1-category lung cancer: findings from a large-scale cohort study","volume":"51","author":"Feng","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1016\/j.clinimag.2025.110416_bb0090","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jtho.2021.11.003","article-title":"The 2021 WHO classification of lung tumors: impact of advances since 2015","volume":"17","author":"Nicholson","year":"2022","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.clinimag.2025.110416_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2021.109802","article-title":"Association of postoperative recurrence with radiological and clinicopathological features in patients with stage IA-IIA lung adenocarcinoma","volume":"141","author":"Zhang","year":"2021","journal-title":"Eur J Radiol"},{"issue":"21","key":"10.1016\/j.clinimag.2025.110416_bb0100","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1200\/JCO.2007.13.9030","article-title":"Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE collaborative group","volume":"26","author":"Pignon","year":"2008","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clinimag.2025.110416_bb0105","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1470-2045(17)30729-5","article-title":"Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II-IIIA (N1\u2212N2) EGFR-mutant NSCLC (ADJUVANT\/CTONG1104): a randomised, open-label, phase 3 study","volume":"19","author":"Zhong","year":"2018","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.clinimag.2025.110416_bb0110","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002142.pub3","article-title":"Postoperative radiotherapy for non-small cell lung cancer","volume":"9","author":"Burdett","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.clinimag.2025.110416_bb0115","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/10543406.2022.2148162","article-title":"Forecasting determinants of recurrence in lung cancer patients exploiting various machine learning models","volume":"33","author":"Thirunavukkarasu","year":"2023","journal-title":"J Biopharm Stat"},{"issue":"9","key":"10.1016\/j.clinimag.2025.110416_bb0120","first-page":"4162","article-title":"Correlation between HRCT signs and levels of CA125, SCCA, and NSE for different pathological types of lung cancer","volume":"27","author":"Wu","year":"2023","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"6","key":"10.1016\/j.clinimag.2025.110416_bb0125","doi-asserted-by":"crossref","first-page":"11145","DOI":"10.3390\/ijms140611145","article-title":"Prognostic value of tumor markers, NSE, CA125 and SCC, in operable NSCLC patients","volume":"14","author":"Yu","year":"2013","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.clinimag.2025.110416_bb0130","first-page":"382","article-title":"Prognostic and predictive biomarkers in early stage NSCLC: CTCs and serum\/plasma markers","volume":"2","author":"Crosbie","year":"2013","journal-title":"Transl Lung Cancer Res"},{"issue":"5","key":"10.1016\/j.clinimag.2025.110416_bb0135","doi-asserted-by":"crossref","first-page":"351","DOI":"10.5761\/atcs.oa.12.01843","article-title":"A clinicopathological study of resected small-sized squamous cell carcinomas of the peripheral lung: prognostic significance of serum carcinoembryonic antigen levels","volume":"19","author":"Nagashima","year":"2013","journal-title":"Ann Thorac Cardiovasc Surg"},{"issue":"5","key":"10.1016\/j.clinimag.2025.110416_bb0140","first-page":"422","article-title":"Prognostic value of serum C-reactive protein (CRP) and cytokeratin 19 fragments (Cyfra 21-1) but not carcinoembryonic antigen (CEA) in surgically treated patients with non-small cell lung cancer","volume":"82","author":"Szturmowicz","year":"2014","journal-title":"Pneumonol Alergol Pol"},{"issue":"7","key":"10.1016\/j.clinimag.2025.110416_bb0145","first-page":"3099","article-title":"Prognostic significance of tumour marker index based on preoperative CEA and CYFRA 21-1 in non-small cell lung cancer","volume":"30","author":"Tomita","year":"2010","journal-title":"Anticancer Res"},{"issue":"2","key":"10.1016\/j.clinimag.2025.110416_bb0150","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/j.jss.2010.04.039","article-title":"Persistently high serum carcinoembryonic antigen levels after surgery indicate poor prognosis in patients with stage I non-small-cell lung cancer","volume":"163","author":"Wang","year":"2010","journal-title":"J Surg Res"},{"issue":"4","key":"10.1016\/j.clinimag.2025.110416_bb0155","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/JTO.0b013e31821038ab","article-title":"A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical IA lung cancer (Japan clinical oncology group 0201)","volume":"6","author":"Suzuki","year":"2011","journal-title":"J Thorac Oncol"},{"issue":"3","key":"10.1016\/j.clinimag.2025.110416_bb0160","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.222422","article-title":"Recurrence patterns and patient outcomes in resected lung adenocarcinoma differ according to ground-glass opacity at CT","volume":"307","author":"Park","year":"2023","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.clinimag.2025.110416_bb0165","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jtho.2019.12.110","article-title":"Validation of the eighth edition clinical T categorization system for clinical stage IA, resected lung adenocarcinomas: prognostic implications of the ground-glass opacity component","volume":"15","author":"Kim","year":"2020","journal-title":"J Thorac Oncol"},{"issue":"2","key":"10.1016\/j.clinimag.2025.110416_bb0170","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jtho.2018.09.026","article-title":"Distinct Clinicopathologic characteristics and prognosis based on the presence of ground glass opacity component in clinical stage IA lung adenocarcinoma","volume":"14","author":"Hattori","year":"2019","journal-title":"J Thorac Oncol"},{"issue":"12","key":"10.1016\/j.clinimag.2025.110416_bb0175","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/j.jtho.2019.08.002","article-title":"Distinct prognostic factors in patients with stage I non-small cell lung Cancer with radiologic part-solid or solid lesions","volume":"14","author":"Fu","year":"2019","journal-title":"J Thorac Oncol"},{"issue":"4","key":"10.1016\/j.clinimag.2025.110416_bb0180","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jtho.2017.11.129","article-title":"Influence of ground glass opacity and the corresponding pathological findings on survival in patients with clinical stage I non-small cell lung Cancer","volume":"13","author":"Aokage","year":"2018","journal-title":"J Thorac Oncol"},{"issue":"1","key":"10.1016\/j.clinimag.2025.110416_bb0185","doi-asserted-by":"crossref","first-page":"6345","DOI":"10.1038\/s41598-022-10318-5","article-title":"Culture and multiomic analysis of lung cancer patient-derived pleural effusions revealed distinct druggable molecular types","volume":"12","author":"Seo","year":"2022","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.clinimag.2025.110416_bb0190","article-title":"Malignant pleural effusion and its current management: a review","volume":"55","author":"Skok","year":"2019","journal-title":"Medicina (Kaunas)"},{"issue":"2","key":"10.1016\/j.clinimag.2025.110416_bb0195","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1563-2571.2001.01008.x","article-title":"Tumor markers","volume":"28","author":"Fiebiger","year":"2001","journal-title":"Acta Med Austriaca"},{"issue":"21","key":"10.1016\/j.clinimag.2025.110416_bb0200","first-page":"377","article-title":"Pleural effusion in adults-etiology, diagnosis, and treatment","volume":"116","author":"Jany","year":"2019","journal-title":"Dtsch Arztebl Int"}],"container-title":["Clinical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707125000166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707125000166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T12:06:49Z","timestamp":1741781209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0899707125000166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":40,"alternative-id":["S0899707125000166"],"URL":"https:\/\/doi.org\/10.1016\/j.clinimag.2025.110416","relation":{},"ISSN":["0899-7071"],"issn-type":[{"type":"print","value":"0899-7071"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A model for prediction of recurrence of non-small cell lung cancer based on clinical data and CT imaging characteristics","name":"articletitle","label":"Article Title"},{"value":"Clinical Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinimag.2025.110416","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110416"}}